Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas

Summary: The patient-derived xenograft (PDX) model is a versatile tool used to study the tumor microenvironment (TME). However, limited studies have described multi-tumor PDX screening strategies to detect hub regulators during cancer-stroma interaction. Transcriptomes of cancer (human) and stroma (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kuniyo Sueyoshi, Daisuke Komura, Hiroto Katoh, Asami Yamamoto, Takumi Onoyama, Tsuyoshi Chijiwa, Takayuki Isagawa, Mariko Tanaka, Hiroshi Suemizu, Masato Nakamura, Yohei Miyagi, Hiroyuki Aburatani, Shumpei Ishikawa
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/49010a93e08142cb8533d7ed48938bcf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:49010a93e08142cb8533d7ed48938bcf
record_format dspace
spelling oai:doaj.org-article:49010a93e08142cb8533d7ed48938bcf2021-11-20T05:09:55ZMulti-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas2589-004210.1016/j.isci.2021.103322https://doaj.org/article/49010a93e08142cb8533d7ed48938bcf2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589004221012918https://doaj.org/toc/2589-0042Summary: The patient-derived xenograft (PDX) model is a versatile tool used to study the tumor microenvironment (TME). However, limited studies have described multi-tumor PDX screening strategies to detect hub regulators during cancer-stroma interaction. Transcriptomes of cancer (human) and stroma (mouse) components of 70 PDX samples comprising 9 distinctive tumor types were analyzed in this study. PDX models recapitulated the original tumors' features, including tumor composition and putative signaling. Particularly, kidney renal clear cell carcinoma (KIRC) stood out, with altered hypoxia-related pathways and a high proportion of endothelial cells in the TME. Furthermore, an integrated analysis conducted to predict paracrine effectors in the KIRC cancer-to-stroma communication detected well-established soluble factors responsible for the hypoxia-related reaction and the so-far unestablished soluble factor, apelin (APLN). Subsequent experiments also supported the potential role of APLN in KIRC tumor progression. Therefore, this paper hereby provides an analytical workflow to find hub regulators in cancer-stroma interactions.Kuniyo SueyoshiDaisuke KomuraHiroto KatohAsami YamamotoTakumi OnoyamaTsuyoshi ChijiwaTakayuki IsagawaMariko TanakaHiroshi SuemizuMasato NakamuraYohei MiyagiHiroyuki AburataniShumpei IshikawaElsevierarticleCancer systems biologyCancerScienceQENiScience, Vol 24, Iss 11, Pp 103322- (2021)
institution DOAJ
collection DOAJ
language EN
topic Cancer systems biology
Cancer
Science
Q
spellingShingle Cancer systems biology
Cancer
Science
Q
Kuniyo Sueyoshi
Daisuke Komura
Hiroto Katoh
Asami Yamamoto
Takumi Onoyama
Tsuyoshi Chijiwa
Takayuki Isagawa
Mariko Tanaka
Hiroshi Suemizu
Masato Nakamura
Yohei Miyagi
Hiroyuki Aburatani
Shumpei Ishikawa
Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
description Summary: The patient-derived xenograft (PDX) model is a versatile tool used to study the tumor microenvironment (TME). However, limited studies have described multi-tumor PDX screening strategies to detect hub regulators during cancer-stroma interaction. Transcriptomes of cancer (human) and stroma (mouse) components of 70 PDX samples comprising 9 distinctive tumor types were analyzed in this study. PDX models recapitulated the original tumors' features, including tumor composition and putative signaling. Particularly, kidney renal clear cell carcinoma (KIRC) stood out, with altered hypoxia-related pathways and a high proportion of endothelial cells in the TME. Furthermore, an integrated analysis conducted to predict paracrine effectors in the KIRC cancer-to-stroma communication detected well-established soluble factors responsible for the hypoxia-related reaction and the so-far unestablished soluble factor, apelin (APLN). Subsequent experiments also supported the potential role of APLN in KIRC tumor progression. Therefore, this paper hereby provides an analytical workflow to find hub regulators in cancer-stroma interactions.
format article
author Kuniyo Sueyoshi
Daisuke Komura
Hiroto Katoh
Asami Yamamoto
Takumi Onoyama
Tsuyoshi Chijiwa
Takayuki Isagawa
Mariko Tanaka
Hiroshi Suemizu
Masato Nakamura
Yohei Miyagi
Hiroyuki Aburatani
Shumpei Ishikawa
author_facet Kuniyo Sueyoshi
Daisuke Komura
Hiroto Katoh
Asami Yamamoto
Takumi Onoyama
Tsuyoshi Chijiwa
Takayuki Isagawa
Mariko Tanaka
Hiroshi Suemizu
Masato Nakamura
Yohei Miyagi
Hiroyuki Aburatani
Shumpei Ishikawa
author_sort Kuniyo Sueyoshi
title Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
title_short Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
title_full Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
title_fullStr Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
title_full_unstemmed Multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
title_sort multi-tumor analysis of cancer-stroma interactomes of patient-derived xenografts unveils the unique homeostatic process in renal cell carcinomas
publisher Elsevier
publishDate 2021
url https://doaj.org/article/49010a93e08142cb8533d7ed48938bcf
work_keys_str_mv AT kuniyosueyoshi multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT daisukekomura multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT hirotokatoh multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT asamiyamamoto multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT takumionoyama multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT tsuyoshichijiwa multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT takayukiisagawa multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT marikotanaka multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT hiroshisuemizu multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT masatonakamura multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT yoheimiyagi multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT hiroyukiaburatani multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
AT shumpeiishikawa multitumoranalysisofcancerstromainteractomesofpatientderivedxenograftsunveilstheuniquehomeostaticprocessinrenalcellcarcinomas
_version_ 1718419538312167424